✦ LIBER ✦

The eligibility for local-regional treatment of peritoneal surface malignancy

✍ Scribed by Vic J. Verwaal; Shigeki Kusamura; Dario Baratti; Marcello Deraco

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 71 KB
Volume: 98
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Morbidity, toxicity, and mortality class

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

✍ Rami Younan; Shigeki Kusamura; Dario Baratti; Alexis-Simon Cloutier; Marcello De 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

The Delphi approach to Attain consensus

The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy

✍ Shigeki Kusamura; Dario Baratti; Rami Younan; Marcello Deraco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Postoperative residual disease evaluatio

Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

✍ Santiago González-Moreno; Shigeki Kusamura; Dario Baratti; Marcello Deraco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract ## Background The maximum size of the residual lesions left behind after cytoreductive surgery for peritoneal surface malignancy has consistently been shown to be the main prognostic factor in this setting. However, a uniform assessment method and categorization for this paramount prog

Regional chemotherapy plus hemofiltratio

Regional chemotherapy plus hemofiltration for the treatment of regionally advanced malignancy

✍ James H. Muchmore 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

he following proportions of cancers are unresectable at the time T of diagnosis: colorectal, 30%; pancreas, 85%; gastric, 60%; and ovarian, 75%. These advanced cancers will most likely involve the entire peritoneal cavity. However, at autopsy, 25-50% are still confined to the abdominal cavity. The s

Two decades of multimodality treatment f

Two decades of multimodality treatment for peritoneal surface malignancies: A tribute to the pioneers of this field

✍ Pompiliu Piso; Aviram Nissan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Hyperthermic regional perfusion with mel

Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities

✍ H. Martijn; J. Oldhoff; H. Schraffordt Koops 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract From September 1969 through 1979, 68 patients with already locally metastasized malignant melanomas of the extremities were treated by hyperthermic regional perfusion and local excision(s). Of these, 53 patients could be evaluated after a follow‐up of at least 2 years: 31 had been perfu